Business Wire

Mundipharma acquires all assets and rights related to REZZAYO ® (rezafungin) , reinforcing continued commitment to management of infectious diseases and specialty care therapeutic area

Share

Mundipharma* today announced the acquisition of all assets and rights related to rezafungin globally from Cidara Therapeutics.

This provides Mundipharma with global ownership of rezafungin including ongoing development and distribution. Rezafunginis a novel once-weekly echinocandin indicated for the treatment of invasive candidiasis in adults.1

Invasive candidiasis, is a severe, life-threatening infection of the bloodstream and/or deep/visceral tissues.2,3 It affects seriously ill people, especially those with a weakened immune systemand the mortality rate can be 40%4 or more.5,6 It can place a large burden on the healthcare system, with the potential for extended treatment regimens and long hospital stays.6 Over the last 15 years, there have been no new treatments and morbidity and mortality rates remain largely the same, indicating the need for alternative treatment options.7,8

“This acquisition places Mundipharma in the best position to realise the full potential of rezafungin including its availability and ongoing development. We are committed to ensuring patients affected with invasive candidiasis have access to an additional treatment option to manage this potentially life-threatening condition,” said Marc Princen, Chief Executive Officer at Mundipharma.

Rezafungin received approval by the U.S. Food and Drug Administration (FDA) in March 20239 and the European Commission (EC) in December 202310. It has also been authorised for use by the UK Medicines and Healthcare Products Regulatory Agency (MHRA) in January 202411 and the UAE Ministry of Health and Prevention (MOHAP) in March 2024. Rezafungin has been granted Orphan Drug Designation for the treatment of invasive candidiasis in the US12, EU13 and UK.14 It is currently available to patients in the UK and Germany, and further marketing authorisation applications are subject to accelerated review procedures to support getting this important medicine to patients.

Commercialisation rights to rezafungin in the United States will remain licensed to Melinta Therapeutics.

*Assets and rights acquired by Napp Pharmaceutical Group Limited, a member of the international network of Mundipharma independent associated companies.

*ENDS*

About invasive candidiasis

Invasive candidiasis (IC) continues to be an area of significant unmet need, especially for critically ill patients in hospitals and patients with compromised immune systems. Despite a number of available treatments, the mortality rate for patients with invasive candidiasis is 40%4 or more.5,6 IC is characterised as a severe, life-threatening systemic Candida infection of the bloodstream and/or deep/visceral tissues, known as candidemia and deep-seated tissue candidiasis.15

About Mundipharma

Mundipharma is a global healthcare company focussing on customers across Africa, Asia Pacific, Canada, Europe, Latin America, and the Middle East.

Mundipharma is dedicated to bringing innovative treatments to patients in the areas of pain management, infectious disease as well as other severe and debilitating disease areas. Their guiding principles, centred around Integrity and Patient-Centricity, are at the heart of everything they do. For more information visit www.mundipharma.com.

References:

  1. REZZAYO® Product Information. EPAR Medicine Overview available at: https://www.ema.europa.eu/en/medicines/human/EPAR/rezzayo (last accessed April 2024).
  2. Pappas PG, et al. Nat Rev Dis Primers 2018 ;4 :18026.
  3. CDC. Invasive candidiasis. Available at: https://www.cdc.gov/fungal/diseases/candidiasis/invasive/definition.html (last accessed April 2024).
  4. Kullberg BJ, Arendrup MC. N Engl J Med 2015;373:1445–56.
  5. Bassetti M, et al. Crit Care 2019;23(1):219.
  6. Cortegiani A, et al. Cochrane Database Syst Rev 2016;2016:Cd004920.
  7. Bassetti M, et al. J Antimicrob Chemother 2018; 73 Suppl 1: i14–i25 doi:10.1093/jac/dkx445.
  8. Ham YY, et al. Future Microbiology 2021;16(1):27–36.
  9. US Food and Drug Administration approval. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2023/217417Orig1s000Approv.pdf (last accessed April 2024)
  10. European Medicines Agency approval. Available at: https://www.ema.europa.eu/en/medicines/human/EPAR/rezzayo#ema-inpage-item-assessment-history (last accessed April 2024).
  11. UK Medicines and Healthcare Products Regulatory Agency authorisation. Available at: https://www.gov.uk/government/news/rezzayo-approved-to-treat-adult-patients-with-invasive-candidiasis (last accessed April 2024).
  12. US Food and Drug Administration. Orphan drug designation notice. Available at: https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=507215 (last accessed April 2024)
  13. European Commission. Orphan maintenance assesment report. Available at: https://www.ema.europa.eu/en/medicines/human/EPAR/rezzayo (last accessed April 2024).
  14. UK MHRA. Register of orphan medicinal products. Available at: https://www.gov.uk/government/publications/orphan-registered-medicinal-products/orphan-register#rezzayo (last accessed April 2024).
  15. Cortes JA, Corrales IF. Invasive candidiasis: Epidemiology and Risk Factors. November 2018. Available at https://www.intechopen.com/chapters/64365 (last accessed April 2024).

Job reference: SciA-RZF-2400003
Date of preparation: April 2024

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Liana Del Medico
VP Communications & Corporate Affairs, Mundipharma
media.relations@mundipharma.com

About Business Wire

Business Wire
Business Wire



Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

AgroAmerica Unveils PlanetA: A Step Forward in Sustainable Food Businesses23.5.2024 19:58:00 CEST | Press release

This year marks a significant milestone for AgroAmerica, a family-owned, vertically integrated company that provides sustainable food and ingredients globally. AgroAmerica proudly launches PlanetA, an ambitious new sustainability strategy aimed at driving tangible change and redefining the paradigms of sustainable food systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240523124865/en/ PlanetA - Sustainability Strategy (Photo: Business Wire) PlanetA emerges from the fusion of AgroAmerica's essence with a profound focus on the planet, underscoring the company's strong commitment to sustainable practices. It embodies the idea that Earth is our only home and everyone’s responsibility, highlighting AgroAmerica's action plan to nurture the planet: our shared home. Under the visionary leadership of AgroAmerica's CEO, Fernando Bolaños, the company embarks on a transformative journey with PlanetA. This comprehensive strategy ad

Canva Unveils Enterprise Era With Powerful New Workplace Products Debuted at Canva Create23.5.2024 18:30:00 CEST | Press release

At its first international Canva Create event in Los Angeles today, Canva, the world’s only all-in-one visual communication platform, accelerated its focus on the enterprise, debuting the platform’s biggest overhaul in a decade alongside a range of new workplace products and services poised to redefine the way millions of people work. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240523849577/en/ Canva Enterprise (Photo: Business Wire) "We are excited to introduce a revamped Canva experience and a suite of new products to empower every organisation to design,” said Melanie Perkins, co-founder and CEO of Canva. “As demand for visual content soars, navigating organizational complexity is more challenging than ever. We democratized the design ecosystem in our first decade and now look forward to unifying the fragmented ecosystems of design, AI, and workflow tools for every organization in our second decade.” As visual communic

Mary Kay Awards Grants to Five Aspiring Young Scientists at Regeneron International Science and Engineering Fair23.5.2024 18:03:00 CEST | Press release

Mary Kay Inc., a corporate cheerleader in support of STEM education and youth pursuing their dreams, recently awarded three grants to five standout high school scientists, selected from nearly 2,000 participants representing almost 70 countries, with grants at the Regeneron International Science & Engineering Fair (ISEF) in Los Angeles. The grants—totaling nearly $10,000—were awarded to students with innovative projects focused on finding cures for cancers affecting women, sustainable packaging innovation, and protecting our planet’s most valuable resources. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240523366610/en/ Mary Kay Inc. proudly served as a Special Award Organization for the 2024 Regeneron International Science and Engineering Fair, awarding three cash prizes to inspiring young scientists. (Graphic: Society for Science, Regeneron ISEF) ISEF, a program of Society for Science for over 70 years, is the world’s lar

Spatial Adds HOOPS Communicator23.5.2024 18:00:00 CEST | Press release

Spatial Corp, the leading software development toolkit provider for design, manufacturing and engineering solutions and a subsidiary of Dassault Systèmes, announced today that it has added HOOPS Communicator, developed by Tech Soft 3D, to complement and extend its portfolio of component technologies. With the addition of HOOPS Communicator to Spatial’s 3D components portfolio, Spatial now enables web-based visualization of and interaction with 3D data for a diverse range of design, engineering and manufacturing workflows. Adding HOOPS Communicator to Spatial’s product portfolio allows its customers to expand their applications to the web while reusing their IP from traditional desktop applications. As a result, Spatial’s customers can leverage many new opportunities on the web, including extended customer-reach, more access control, and less costly distributions, updates and maintenance. “We are excited to enhance our portfolio by adding HOOPS Communicator. This addition enables Spatia

WORLD’S MOST ICONIC ROCK BAND, THE ROLLING STONES, SELECTS THUNDER RIDGE NATURE ARENA AS DESTINATION FOR FINAL NORTH AMERICAN PERFORMANCE23.5.2024 18:00:00 CEST | Press release

Bass Pro Shops Big Cedar Lodge announced today that on July 21 the Ozarks will rock as the ancient hills, valleys and lakes never have when the world’s greatest rock-and-roll band, The Rolling Stones, light up Thunder Ridge Nature Arena for the last performance on their final North American tour. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240523211894/en/ Rendering of Thunder Ridge Nature Arena (Graphic: Business Wire) The concert promises to be one of the most memorable and highly anticipated concert events ever. It is a pairing of the World’s Greatest Rock-and-Roll Band and the most breathtaking and awe-inspiring outdoor amphitheater in all of North America. The Thunder Ridge concert stop is part of the “Hackney Diamonds Tour ’24” for The Rolling Stones, which includes 20 performances in 16 cities. Tickets will go on sale Friday, May 31, and will be available at ThunderRidgeNatureArena.com. “We’re honored to host The R

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye